{"status": "OK", "response": {"docs": [{"type_of_material": "News", "blog": [], "news_desk": "Business/Financial Desk", "lead_paragraph": "The Schering-Plough Corporation said yesterday that it could soon be indicted in a federal investigation into its prescription drug marketing practices, and face charges that employees destroyed documents related to the case. According to the company, prosecutors are examining whether Schering-Plough illegally gave financial grants and other items of value to doctors and other customers, whether it marketed drugs for unapproved uses and whether it submitted false pricing information to the government so that Medicaid paid too much for its products.", "headline": {"main": "Indictment Seen By Drug Maker Over Marketing"}, "abstract": "Schering-Plough Corp expects to be indicted in federal investigation into its prescription drug marketing practices; most significant charge being weighed by grand jury is obstruction of justice; company says prosecutors are also examining whether it illegally gave financial grants and other items of value to doctors and other customers, whether it marketed its drugs for unapproved uses and whether it submitted false pricing information to government, thereby inflating Medicaid prices; allegations are latest in spate of investigations and suits focused on pharmaceutical industry's marketing practices; Schering says it has made changes in its sales and marketing practices, and that it is cooperating with investigation, which began more than two years ago; company declines to comment about specifics involving charge of document destruction; if company is convicted, government could seek to bar its drugs from federal Medicare and Medicaid programs, which would have devastating effect on business; other cases against pharmaceutical companies discussed; photo (L)", "print_page": "1", "word_count": 1221, "_id": "4fd22b828eb7c8105d7b70e6", "snippet": "The Schering-Plough Corporation said yesterday that it could soon be indicted in a federal investigation into its prescription drug marketing practices, and face charges that employees destroyed documents related to the case.    According to the...", "source": "The New York Times", "slideshow_credits": null, "web_url": "http://www.nytimes.com/2003/05/31/business/indictment-seen-by-drug-maker-over-marketing.html", "multimedia": [], "subsection_name": null, "keywords": [{"name": "organizations", "value": "SCHERING-PLOUGH CORP"}, {"name": "subject", "value": "SALES"}, {"name": "subject", "value": "FRAUDS AND SWINDLING"}, {"name": "subject", "value": "MISLEADING AND DECEPTIVE ADVERTISING"}, {"name": "subject", "value": "ADVERTISING AND MARKETING"}, {"name": "subject", "value": "DRUGS (PHARMACEUTICALS)"}, {"name": "subject", "value": "MEDICAID"}, {"name": "subject", "value": "PRICES (FARES, FEES AND RATES)"}, {"name": "subject", "value": "SUITS AND LITIGATION"}, {"name": "subject", "value": "ETHICS"}, {"name": "subject", "value": "DOCTORS"}, {"name": "subject", "value": "MEDICARE"}, {"name": "subject", "value": "MEDICINE AND HEALTH"}], "byline": {"person": [{"organization": "", "role": "reported", "rank": 1, "firstname": "Melody", "lastname": "PETERSEN"}], "original": "By MELODY PETERSEN"}, "document_type": "article", "pub_date": "2003-05-31T00:00:00Z", "section_name": "Front Page; Health; Business"}], "meta": {"hits": 1, "offset": 0, "time": 27}}, "copyright": "Copyright (c) 2013 The New York Times Company.  All Rights Reserved."}